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Abstract
Background: We estimate the effect of antibiotics given in the intrapartum period on early-onset neonatal sepsis
in Dhaka, Bangladesh using propensity score techniques.
Methods: We followed 600 mother-newborn pairs as part of a cohort study at a maternity center in Dhaka. Some
pregnant women received one dose of intravenous antibiotics during labor based on clinician discretion. Newborns
were followed over the first seven days of life for early-onset neonatal sepsis defined by a modified version of the
World Health Organization Young Infants Integrated Management of Childhood Illnesses criteria.
Using propensity scores we matched women who received antibiotics with similar women who did not. A final
logistic regression model predicting sepsis was run in the matched sample controlling for additional potential
confounders.
Results: Of the 600 mother-newborn pairs, 48 mothers (8.0%) received antibiotics during the intrapartum period.
Seventy-seven newborns (12.8%) were classified with early-onset neonatal sepsis. Antibiotics appeared to be
protective (odds ratio 0.381, 95% confidence interval 0.115–1.258), however this was not statistically significant. The
results were similar after adjusting for prematurity, wealth status, and maternal colonization status (odds ratio 0.361,
95% confidence interval 0.106–1.225).
Conclusions: Antibiotics administered during the intrapartum period may reduce the risk of early-onset neonatal
sepsis in high neonatal mortality settings like Dhaka.
Keywords: Intrapartum antibiotics, Early-onset neonatal sepsis, Propensity scores, Bangladesh
Background
Neonatal infections - including sepsis, pneumonia, and
meningitis - account for approximately 23.4% of the
world’s 3.1 million neonatal deaths each year [1]. In de-
veloping countries, where 99% of neonatal deaths occur,
up to 42% of infection related deaths occur in the first
week of life [2]. This narrow time period provides only a
small window of opportunity for interventions.
In Bangladesh, the incidence of clinical sepsis during
the first week of life defined by the World Health
Organization (WHO) Young Infants criteria for very
severe disease [3] was 13.4% with a case-fatality of 10.2%
[4] and the incidence of community-acquired neonatal
bacteremia was 1.4 per 1000 live births [5]. The most
common pathogen isolated was S. aureus [5].
Maternal infections and risk factors for infection or
colonization increase the possibility of early-onset neo-
natal infections by vertical transmission [6]. Several inter-
ventions have been proposed to decrease the transmission
of bacterial pathogens from the mother to newborn, par-
ticularly in preventing Group B Streptococcus (GBS)
early-onset neonatal sepsis. For example, vaccines against
the nine identified GBS stereotypes have been developed
[7] and are currently being tested [8]. Another strategy is
vaginal washes with chlorhexidine, which have been
shown to reduce GBS bacterial load but did not affect
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vention is antibiotics given during the intrapartum period.
Administration of antibiotics during the intrapartum
period (most often penicillin) decreases vaginal GBS co-
lony counts [11] and is thought to decrease the con-
centration of bacteria in the maternal bloodstream and
amniotic fluid. Currently, in high income countries, indi-
cations for intrapartum antibiotic prophylaxis to prevent
GBS early-onset neonatal sepsis are based on universal
culture-based screening [12]. After implementation of
the initial guidelines in 1996, a decreasing GBS inci-
dence has been observed over time (1.7 per 1000 live
births in 1993 compared to 0.34–0.37 per 1000 in recent
years) [12-14].
Although the use of antibiotics during the intrapartum
period has been widely adopted in high income countries,
the evidence supporting antibiotic use derives mainly from
cohort studies. There are limited data from randomized
controlled trials and most are on GBS. A recent Cochrane
review on antibiotics during the intrapartum period for
known GBS maternal colonization identified only four
randomized controlled trials, most of which were from
the 1980s to early 2000s. Intrapartum antibiotics appeared
to reduce GBS early-onset sepsis, however these findings
may have been the result of a high risk of bias in the stu-
dies. The review concluded there was insufficient evidence
to recommend intrapartum antibiotics to reduce GBS
early-onset neonatal sepsis [15]. Furthermore, in regions
like South Asia where the incidence of GBS early-onset
sepsis was 0.02 per 1000 live births [16], it is unclear
whether intrapartum antibiotics would reduce sepsis from
other organisms.
Because there is a lack of randomized controlled trials
and a dearth of data in particular from developing coun-
tries, we estimate the causal effect of intrapartum anti-
biotics on early-onset neonatal sepsis using propensity
score matching in a cohort study of mother-newborn
pairs in Dhaka, Bangladesh. Understanding the effect of
intrapartum antibiotics on early-onset neonatal sepsis
may lead to strategies to prevent sepsis and its asso-
ciated morbidities and mortality globally.
Methods
Ethics statement
This study received ethical approval from the Johns
Hopkins Bloomberg School of Public Health Committee
on Human Research and the International Center for
Diarrheal Disease Research, Bangladesh Ethical Review
Committee. All study participants provided written in-
formed consent. Parents or guardians gave informed
consent on behalf of their newborns. Pregnant women
in active labor initially provided verbal consent and then
full written consent after delivery.
This study analyzes data collected as part of a cohort
study, Maternal Origins of Neonatal Infection (MONI),
which followed 600 mother-newborn pairs from January
15, 2011 to October 31, 2011 at a maternity center ope-
rated by Shimantik, a partner non-governmental organi-
zation in Dhaka, Bangladesh.
In the cohort study, pregnant women who planned to
deliver at the maternity center were enrolled after 30
weeks gestation. Women with fetal distress, obstructed
labor, hemorrhage, or severe pre-eclampsia were ex-
cluded to facilitate their need for urgent care. Women
with antibiotic or steroid use two weeks before labor
were excluded. Newborns who were delivered by cae-
sarean section were excluded since the route of bacterial
transmission differs by type of delivery and all women
who delivered by caesarean sections at this facility re-
ceived antibiotics. Newborns with birth injuries or sur-
gical conditions requiring urgent care were excluded.
Newborns were followed over the first seven days of life.
As part of the cohort study, Shimantik recruited four
paramedics and five community health workers for pri-
mary data collection. Paramedics completed higher se-
condary school (12 years) and the national paramedics
course. Community health workers finished at least se-
condary school (10 years). Two medical officers, one for
field supervision and the other for quality assurance,
were part of the study team. Staff received a two-week
intensive training course by a pediatrician and local
medical officer using the WHO Caring for the Newborn
at Home training course for community health workers
[17]. Sessions included presentations on basic principles,
exercises and role plays on the recognition of clinical
signs and symptoms, and field experiences in homes.
Written exams and standardized observations were ini-
tially conducted and periodically repeated to maintain
high levels of staff competency.
Demographic factors that may influence the receipt of
antibiotics during labor and the incidence of early-onset
sepsis were collected. Study paramedics collected data
on maternal education, maternal age, antenatal care pro-
vider type, and receipt of tetanus toxoid as a proxy for
access to health care. Wealth quintiles were created
using principal components analysis with the following
variables: construction of household materials, type of
latrine, source of water, household number, number of
children under five living in the household, and number
of rooms where household members sleep [18].
At least one study paramedic was present around the
clock in the labor and delivery room to assess maternal
risk factors: stage and duration of labor, rupture of
membranes, intrapartum temperature, number of vagi-
nal exams performed, amniotic fluid color, hand washing
by health workers, and maternal reproductive tract
colonization status during labor. Women with a positive
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were classified as colonized. Culture results were not
available prior to delivery. Paramedics also collected data
on neonatal characteristics such as sex, birth weight to
the nearest 100 grams, and gestational age based on
ultrasound report or maternal report of the date of last
menstrual period.
During labor, some women were given one dose of
intravenous antibiotics based on clinician discretion.
Possible indications for antibiotics included episiotomy,
failed trial of labor at home or delivery center, or early
rupture of membranes. In Bangladesh, there are cur-
rently no established protocols for intrapartum antibiotic
administration. Study paramedics observed and recorded
any maternal receipt of intrapartum antibiotics.
The primary outcome measure was early-onset neo-
natal sepsis defined as a positive blood culture or clas-
sification of very severe disease by a physician or a
community health worker following a modified version
of the WHO Young Infants Integrated Management of
Childhood Illnesses criteria (not able to feed or suck,
history of convulsions, movement only when stimulated,
respiratory rate >60 per min, severe chest indrawing,
axillary temperature ≥37.5°C, axillary temperature ≤35.5°C)
[3] without the diagnosis of asphyxia. Newborns were ex-
amined by a study physician before discharge from the
maternity center and at home during days of life three and
seven by community health workers. On days of life two,
four, five, and six, community health workers conducted
phone follow-ups. Newborns identified as sick by commu-
nity health workers were evaluated by a study physician.
Statistical analysis
We used propensity score matching to create groups of
antibiotic-treated pregnant women and control (not re-
ceiving antibiotics) pregnant women who were similar
with respect to observed characteristics [19]. Propensity
scores, which reflect each pregnant woman’s predicted
probability of receiving intrapartum antibiotics given a
set of observed covariates, were created by a logistic
regression model predicting receipt of antibiotics as a
function of baseline characteristics and maternal risk
factors. See Table 1 for a list of the 23 covariates used to
create the propensity scores.
We initially considered three matching methods: one-
to-one matching with replacement, full constrained
matching, and full unconstrained matching and selected
the one method that best balanced covariates between
the treated and control group. One-to-one matching
selected for each treated woman the control woman with
the most similar propensity score. After each match, the
selected control was replaced into the control group and
available for subsequent matching (i.e., matching was
done “with replacement”). Controls not selected as a
match were discarded and not used in subsequent ana-
lyses. Full matching retains all individuals and creates
subgroups with at least one treated and one control with
similar propensity scores. Treated and control individuals
who did not have a good match (were outside the range
of the propensity scores of the other group) were dis-
carded. Following full matching, a weighting approach
was used to account for multiple treated and control in-
dividuals in each subgroup, as described below. Full
unconstrained matching did not limit the number of
treated and control individuals in each subgroup while
constrained full matching restricted the maximum num-
ber of controls to 10 per treated [20-22].
To check balance, we calculated the standardized dif-
ference for each covariate: the difference in means bet-
ween the treated and control groups divided by the
standard deviation in the control group, calculated before
and after matching. We choose the matching method that
yielded the smallest standardized bias across most of the
covariates before running the final outcome regression
models.
These methods estimated the average treatment effect
among the treated individuals, in other words, the aver-
age outcome among the treated individuals compared to
if they had not been treated [23]. In full matching, where
there may be multiple treated and controls within each
matched set, we utilized a weighted approach where
control individuals are weighted to the treatment group.
In particular, within each matched set, treated indi-
viduals received a weight of one. Control individuals re-
ceived a weight proportional to the number of treated
individuals in their matched set divided by the number
of control individuals in their matched set, with the con-
trol weights scaled to sum to the total number of con-
trols matched in the data [24]. These weights were then
used in the final logistic regression model estimating the
effect of intrapartum antibiotics on early-onset neonatal
sepsis.
For variables with missing data, we imputed the mean
of the variable. For those variables with more than 5%
missing values we included in the propensity score model
the variable itself as well as a missing data indicator [25].
We conducted a sensitivity analysis comparing the esti-
mates resulting from this approach with those from a
complete case analysis that excluded observations with
missing data.
We also present results with a traditional logistic regres-
sion models without propensity score matching for com-
parison. In both models, the propensity score matched
and traditional logistic regression without propensity
score matching, we performed a crude analysis as well as
an adjusted analysis controlling for the potential con-
founders that were associated with sepsis (p<0.10): pre-
maturity, maternal colonization status, and wealth status.
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Treatment - intrapartum antibiotics Outcome - sepsis
#n o
abx (n)
% # with
abx (n)
% p-value # no
sepsis (n)
% # with
sepsis (n)
% p-value
Total 552 48 523 77
Preterm 62 11.23 4 8.33 53 10.13 13 16.88
No preterm 398 72.1 38 79.17 0.468 386 73.8 50 64.94 0.060
Missing 92 16.67 6 12.5 0.574 84 16.06 14 18.18 0.158
Low birth weight <2500 grams 92 16.67 7 14.58 85 16.25 14 18.18
Not low birth weight 419 75.91 38 79.17 0.681 398 76.1 59 76.62 0.742
Missing 41 7.43 3 6.25 0.878 40 7.65 4 5.19 0.703
No tetanus toxoid 58 10.51 4 8.33 52 9.94 10 12.99
Received tetanus toxoid 493 89.31 43 89.58 0.663 467 89.67 67 87.01 0.419
Missing 1 0.18 1 2.08 0.082 2 0.38 0 0 0.622
Antenatal care from a provider
other than doctor
409 74.09 25 52.08 376 71.89 58 75.32
Antenatal care from doctor 123 22.28 21 43.75 0.001 127 24.28 17 22.08 0.630
Missing 20 3.62 2 4.17 0.003 20 3.82 2 2.6 0.771
Mom no schooling 114 20.65 6 12.5 100 19.12 20 25.97
Mom schooling 438 79.35 41 85.42 0.195 422 80.96 57 74.03 0.163
Missing 0 0 1 2.08 0.001 1 0.19 0 74.03 0.351
Maternal age< =22 272 49.28 22 45.83 253 48.37 41 53.25
Maternal age >22 280 50.72 26 54.17 0.647 270 51.63 36 46.75 0.425
Roof tin, straw, leaf, bamboo 431 78.08 32 66.67 399 76.29 64 83.12
Roof concrete, brick, cement 121 21.92 16 33.33 0.071 124 23.71 13 16.88 0.183
Wall tin, straw, leaf, bamboo, mud 216 39.13 14 29.17 199 38.05 31 40.26
Wall concrete, brick, cement 336 60.87 34 70.83 0.173 324 61.95 46 59.74 0.710
Floor semi concrete, wood, straw,
leaf, bamboo, mud
117 21.2 7 14.58 110 21.03 14 18.18
Floor concrete 435 78.8 41 85.42 0.278 413 78.97 63 81.82 0.564
Household number >3 281 50.91 19 39.58 255 48.76 45 58.44
Household number<=3 271 49.09 28 58.33 0.168 267 51.05 32 41.56 0.116
Missing 0 0 1 2.08 0.001 1 0.19 0 0 0.270
Number of children under 5> 0 131 23.73 13 27.08 122 23.33 22 28.57
Number of children under 5= 0 421 76.27 34 70.83 0.545 400 76.48 55 71.43 0.319
Missing 0 0 1 2.08 0.003 1 0.19 0 0 0.565
Household latrine slab or hanging 210 38.04 13 27.08 192 36.71 31 40.26
Household latrine sanitary 342 61.96 34 70.83 0.157 330 63.1 46 59.74 0.556
Missing 0 0 1 2.08 0.001 1 0.19 0 0 0.781
Household drinking water source tube 249 45.11 15 31.25 223 42.64 41 53.25
Household drinking water source tap 303 54.89 32 66.67 0.080 299 57.17 36 46.75 0.082
Missing 0 0 1 2.08 0.001 1 0.19 0 0 0.205
Wealth (upper quintile of wealth)* 118 21.38 16 33.33 121 23.14 13 16.88
Wealth (lower four quintiles) 434 78.62 31 64.58 0.045 401 76.67 64 83.12 0.431
Missing 0 0 1 2.08 <0.001 1 0.19 0 0 0.216
Active labor 239 43.3 15 31.25 216 41.3 38 49.35
Early labor 274 49.64 29 60.42 0.110 269 51.43 34 44.16 0.190
Missing 39 7.07 4 8.33 0.269 38 7.27 5 6.49 0.409
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College Station, TX). Statistical analyses were conducted
in R, version 2.14.0, with the propensity score matching
conducted using the MatchIt package [24].
Results
Of the 600 mother-newborn pairs enrolled, 48 mothers
(8.0%) received intrapartum antibiotics. The most com-
monly used intravenous antibiotics were one dose of
cephalexin 500 mg (79.1%), amoxicillin 500 mg (16.7%), or
penicillin 500 mg (4.2%). Seventy-seven newborns (12.8%)
were classified with early-onset neonatal sepsis; three of
whom were born to treated mothers. Physicians diagnosed
or confirmed the diagnosis in 44 newborns. Kappa sta-
tistics show substantial agreement (к=0.63) between as-
sessments of very severe disease by community health
workers and physicians. All peripheral blood cultures
(n=12) obtained among newborns diagnosed with clinical
early-onset neonatal sepsis were negative. The most com-
mon organisms detected from maternal vaginal cultures
were S. aureus (7.4%), Non-GBS streptococcus (6.8%), and
GBS (6.2%).
Several baseline characteristics were associated with
receipt of intrapartum antibiotics and early-onset neo-
natal sepsis (Table 1). Factors associated with intra-
partum antibiotic use included receipt of antenatal care
from physicians (43.8% vs. 22.3%, p =0.001), homes with
roofs made of concrete, brick, or cement (33.3% vs.
21.9%, p =0.07), drinking water sources from the tap ra-
ther than tube well (66.7% vs. 54.9%, p= 0.08), upper
quintile of wealth (33.3% vs. 21.4%, p=0.05), and rup-
ture of membranes at presentation (60.4% vs. 39.0%,
Table 1 Covariates by treatment (intrapartum antibiotics) and outcome (neonatal sepsis) (Continued)
Time in labor> =8 hours 277 50.18 22 45.83 257 49.14 42 54.55
Time in labor< 8 hours 263 47.64 26 54.17 0.468 254 48.57 35 45.45 0.487
Missing 12 2.17 0 0 0.449 12 2.29 0 0 0.317
Rupture of membranes at presentation 215 38.95 29 60.42 216 41.3 28 36.36
No rupture of membranes at presentation 326 59.06 19 39.57 0.005 296 56.6 49 63.64 0.333
Missing 11 1.99 0 0 0.012 11 2.1 0 0 0.273
Premature rupture of membranes 50 9.06 6 12.5 47 8.99 9 11.69
No premature rupture of membranes 491 88.95 42 87.5 0.461 465 88.91 68 88.31 0.484
Missing 11 1.99 0 0 0.466 11 2.1 0 0 0.342
Amniotic Fluid green or cloudy 97 17.57 6 12.5 91 17.4 12 15.58
Amniotic Fluid clear 432 78.26 40 83.33 0.369 409 78.2 63 81.82 0.643
Missing 23 4.17 2 4.17 0.668 23 4.4 2 2.6 0.683
Maternal temperature >=99 27 4.89 1 2.08 24 4.59 4 5.19
Maternal temperature <99 492 89.13 47 97.92 0.340 470 89.87 69 89.61 0.819
Missing 33 5.98 0 0 0.136 29 5.54 4 5.19 0.966
Number of vaginal exams performed>=3 263 47.64 27 56.25 251 47.99 39 50.65
Number of vaginal exams< 3 276 50 20 41.67 0.255 529 49.52 37 48.05 0.733
Missing 13 2.36 1 2.08 0.519 13 2.49 1 1.3 0.766
No hand washing before vaginal exam 134 24.28 15 31.25 130 24.86 19 24.68
Hand washing before exam 395 71.56 32 66.67 0.323 370 70.75 57 74.03 0.853
Missing 23 4.17 1 2.08 0.474 23 4.4 1 1.3 0.424
No hand washing before delivery 34 6.16 2 4.17 31 5.93 5 6.49
Hand washing before delivery 497 90.04 44 91.67 0.580 470 89.87 71 92.21 0.895
Missing 21 3.8 2 4.17 0.852 22 4.21 1 1.3 0.459
Colonization 202 36.59 17 35.42 184 35.18 35 45.45
No colonization 337 61.05 29 60.42 0.944 326 62.33 40 51.95 0.080
Missing 13 2.36 2 4.17 0.741 13 2.49 2 2.6 0.209
Antibiotics* 45 8.6 3 3.9
No antibiotics 478 91.4 74 96.1 0.155
*Not used to calculate propensity score.
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sepsis were prematurity (16.9% vs. 10.1%, p=0.06), colo-
nized mothers (45.5% vs. 35.2%, p =0.08), and homes
with drinking water sources from a tube well rather than
tap (53.3% vs. 42.6%, p=0.08).
Across the three matching methods considered, full
unconstrained matching had the best overall balance
across the covariates. After matching, the absolute stan-
dardized biases ranged from −0.19 to 0.18. The variable
with the maximum standardized difference (−0.19) was
no hand washing before vaginal exam. See Additional
file 1: Table S1 for a summary of balance for matched
and unmatched data. The full unconstrained method
matched 500 controls and 48 treated women (52 con-
trols were discarded).
Using the propensity score matched dataset (n=548),
there was a reduction in sepsis rates, although not statisti-
cally significant, between newborns of mothers who re-
ceived intrapartum antibiotics and newborns of mothers
who did not receive intrapartum antibiotics (odds ratio
[OR] 0.381, 95% confidence interval [CI] 0.115–1.258).
The result was similar after adjusting for prematurity,
wealth status, and maternal colonization status (OR 0.361,
95% CI 0.106–1.225) (Table 2).
We conducted a sensitivity analysis with a complete
case dataset (n =408) that excluded observations with
missing data. Matching with the full unconstrained
method yielded 280 controls and 38 treated women
(90 controls were discarded). Again there was a reduc-
tion, not statistically significant, in sepsis rates between
the antibiotic group compared to the control group (OR
0.160, 95% CI 0.021–1.197). The results were similar
after adjusting for prematurity, the highest wealth quin-
tile, and maternal colonization status (OR 0.170, 95% CI
0.022–1.295).
Analysis with traditional logistic regression models
(n =600) without propensity score matching showed
similar results. There was a reduction in sepsis rates, not
statistically significant, between the antibiotic and con-
trol groups (OR 0.431, 95% CI 0.130–1.421), with similar
results after adjusting for prematurity, the highest wealth
quintile, and maternal colonization status (OR 0.458,
95% CI 0.138–1.521).
Since the number of sepsis cases in the treated group
were small, we also compared p-values from a Fisher’s
exact test of treatment and sepsis (p=0.182) with the pro-
pensity score unmatched logistic regression (p=0.167)
and found little difference.
Discussion
Antibiotics during labor suggest a decreased risk, although
not statistically significant, of early-onset neonatal sepsis
in this population. A reduction of early-onset neonatal
sepsis by 64%, if confirmed, is clinically important.
Our findings are robust across the different approaches
and methods with similar point estimates and confidence
intervals. The propensity score matched adjustment esti-
mate is somewhat larger in magnitude compared to the
result from traditional regression analysis. Prior to pro-
pensity score matching, the observed covariates were
imbalanced between the treated and control groups, par-
ticularly rupture of membranes at presentation and ante-
natal care provider type. Propensity score matching
reduced confounding by indication by achieving better
balance of the observed covariates across the treated and
control groups. We further adjusted for confounders by
fitting a regression model assuming a normal logistic re-
gression of sepsis given antibiotic use and the observed
covariates.
Our sensitivity analysis, a complete case analysis rather
than a single imputation of missing values, further de-
creased the number of sepsis cases in the treatment
group (to 1) which may have contributed to a more pro-
tective odds in that sensitivity analysis suggesting that
our data were missing not at random.
There are few randomized controlled trials that exa-
mined intrapartum antibiotics and early-onset neonatal
sepsis. A study by Matorras et al. (1990) in Spain found
that administration of intrapartum ampicillin to GBS colo-
nized women decreased GBS positive culture cases of
early-onset sepsis by 85% and cases of clinical early-onset
sepsis by 78% [26]. In Finland, a study by Tuppurainen
Table 2 Effect of intrapartum antibiotics and early-onset neonatal sepsis models: propensity score (PS) matched
adjustment, propensity score matched adjustment complete case analysis, and traditional logistic regression no
propensity score matching
Model Treated Controls OR 95% CI
Propensity score matched unadjusted 48 500 0.381 0.115–1.258
Propensity score matched adjusted* 48 500 0.361 0.106–1.225
PS matched complete case analysis unadjusted 38 280 0.160 0.021–1.197
PS matched complete case analysis adjusted* 38 280 0.170 0.022–1.295
Traditional logistic regression no PS matching unadjusted 48 552 0.431 0.130–1.421
Traditional logistic regression no PS matching adjusted* 41 451 0.458 0.138–1.521
*The adjusted analyses controlled for prematurity, wealth status, and maternal colonization status.
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nized women during labor reduced GBS positive culture
cases of early-onset sepsis by 75% and cases of clinical
early-onset sepsis by 83% [27]. However, in neither study
was the reduction statistically significant (a similar sce-
nario as what we found here). One randomized controlled
trial by Gibbs (1988) found that ampicillin and gentamicin
administered to women with intra-amniotic infections
during labor was associated with a statistically significant
reduction in early-onset neonatal sepsis (clinical or culture
confirmed) (OR 0.04, 95% CI 0.00–0.75) [28]. All three of
these studies targeted high risk pregnant women with
intra-amniotic infections or colonization with GBS.
In our study, we included all women regardless of
their risk status. In low-resource settings like Bangladesh
the ability to implement a universal screen using vaginal
swabs would be limited. However, a risk factor and cli-
nical symptoms screen may be feasible and useful to test
in such a setting.
Antibiotic choice depends on local knowledge of the eti-
ology of maternal colonization and neonatal sepsis and
antibiotic resistance patterns. In our facility, most women
received the standard first generation cephalosporin, ce-
phalexin, which provides excellent gram positive coverage.
An earlier study at the same facility found that the most
prevalent organism in the maternal vaginal tract was
S. aureus, which was also one of the most common etio-
logies of neonatal bacteremia in Bangladesh [5]. However,
approximately 25% of S. aureus isolates were resistant to
cephalexin in a community-based study in Bangladesh [5].
The study has several limitations. We assume there are
no unobserved differences between the treatment and
control groups given the observed variables; we are only
able to adjust for observed confounders. We had more
than 5% missing data on gestational age, birth weight, and
maternal temperature; we used sensitivity analysis to
examine robustness across how we handled this missing
data. We had limited neonatal blood culture data due to
low compliance with referrals to tertiary care centers.
Therefore, our primary outcome measure of neonatal
sepsis relied on clinical signs and symptoms, which is
overly sensitive and nonspecific. However, newborns of
mothers with or without intrapartum antibiotics were
non-differentially classified as having sepsis. This non-
differential misclassification would have underestimated
our effect size. As stated above, our dataset is of rela-
tively small size. Our effective sample size following
matching was 89 controls and 48 treated, implying that
we had less than 80% power to detect an effect of the
size that we found. But the data provides our best in-
formation at this point about these associations. Ad-
ditional, and larger, studies are needed to confirm these
results. The provision of antibiotics was based on cli-
nician discretion without a set protocol, which allowed
us to mimic randomization of women to antibiotics or
control based on a set of similar observed characteristics.
To our knowledge, this is the first study that uses pro-
pensity scores to determine the effects of intrapartum
antibiotics on early-onset neonatal sepsis in developing
country settings. Given the challenges of conducting a
randomized controlled trial in settings where intra-
partum antibiotic prophylaxis is widely accepted for GBS
colonization like the United States and the lack of pre-
liminary data in countries like Bangladesh, this is an
attractive method that represents a strong design to in-
vestigate the causal effects of antibiotic prophylaxis
and early-onset neonatal sepsis [19].
Including intrapartum antibiotics as part of a compre-
hensive neonatal survival package has the potential to
save many lives. Given the potential for tremendous
benefit, a double-blind randomized controlled trial test-
ing the effect of intrapartum antibiotics on early-onset
neonatal sepsis or larger studies using propensity score
matching would be ideal. Current evidence from ran-
domized controlled trials is inconclusive and limited
only to GBS [29]. In designing future studies, we need to
examine the frequency and timing of antibiotic doses re-
quired, the optimal antibiotic choice depending on the
geographic variability of organisms, and possible risks.
Future studies would provide needed knowledge for
areas where intrapartum antibiotics prophylaxis is cur-
rently given and support or nullify the use of intra-
partum antibiotics in low-resource settings.
Conclusion
Antibiotics during labor indicated a strong protection
against early-onset neonatal sepsis (OR=0.36), but the
relative size of our population did not yield a level of sta-
tistical significance. In settings where the burden of
neonatal mortality is disproportionately high, additional
studies with larger datasets using propensity scores or ran-
domized controlled trials testing the effect of intrapartum
antibiotics on early-onset neonatal sepsis are warranted.
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